RLITX | VTMNX | RLITX / VTMNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 24 years | - |
Gain YTD | 0.668 | 2.774 | 24% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.32B | 197B | 2% |
Annual Yield % from dividends | 1.38 | 3.27 | 42% |
Returns for 1 year | 8.67 | 9.81 | 88% |
Returns for 3 years | -8.92 | -5.36 | 166% |
Returns for 5 years | 14.45 | 16.74 | 86% |
Returns for 10 years | N/A | 33.04 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTIX | 59.94 | 0.32 | +0.54% |
Baron Fifth Avenue Growth Instl | |||
LVFLX | 14.02 | N/A | N/A |
Lord Abbett Focused Large Cap Value R6 | |||
LBRIX | 32.62 | -0.03 | -0.09% |
ClearBridge Dividend Strategy FI | |||
FAVCX | 24.73 | -0.05 | -0.20% |
Fidelity Advisor Equity Value C | |||
FBTCX | 25.11 | -0.37 | -1.45% |
Fidelity Advisor Biotechnology C |